A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia

Intermediate risk acute myeloid leukemia (AML) comprises around 50% of AML patients and is featured with heterogeneous clinical outcomes. The study aimed to generate a prediction model to identify intermediate risk AML patients with an inferior survival. We performed targeted next generation sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoxia, Wang, Bianhong, Chen, Qi, Huang, Aijie, Fu, Weijia, Liu, Lixia, Zhang, Ying, Tang, Gusheng, Cheng, Hui, Ni, Xiong, Gao, Lei, Chen, Jie, Chen, Li, Zhang, Weiping, Yang, Jianmin, Cao, Shanbo, Yu, Li, Wang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247394/
https://www.ncbi.nlm.nih.gov/pubmed/34234861
http://dx.doi.org/10.7150/jca.57231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247394/
https://www.ncbi.nlm.nih.gov/pubmed/34234861
http://dx.doi.org/10.7150/jca.57231

Ejemplares similares